Latest News about BNTX
Recent news which mentions BNTX
Pfizer/BioNTech COVID-19 Booster Shots Get Recommendation From European Medicine Agency
October 04, 2021
From Benzinga
How David Green Traded Moderna For A Big Profit On Monday Morning
October 04, 2021
From Benzinga
U.S. COVID-19 cases and hospitalizations continue to decline, but experts lament preventable deaths that have pushed toll above 700,000
October 04, 2021
From MarketWatch
Why BioNTech Shares Are Trading Lower Again Today
October 04, 2021
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 04, 2021
From Benzinga
Buy the dip has failed. Here’s what investors need to do next, says Morgan Stanley.
October 04, 2021
From MarketWatch
Avoid Zoom as It Grapples With Reopening, Tough Competitors
October 04, 2021
From InvestorPlace
From Motley Fool
54 Biggest Movers From Friday
October 04, 2021
From Benzinga
From MarketWatch
3 Top Dividend Stocks to Buy in October
October 03, 2021
From Motley Fool
Merck Shouldn't Matter to the Nasdaq's Vaccine Stocks
October 01, 2021
From Motley Fool
Why Pfizer, BioNTech, Novavax, and Vaxart Stocks Are Sinking Today
October 01, 2021
From Motley Fool
From Benzinga
From Benzinga
The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO
October 01, 2021
From Benzinga
From Motley Fool
3 Most Overvalued Biotech Stocks on the Market Right Now
October 01, 2021
From Motley Fool
Why Moderna, BioNTech, and Novavax Stocks Are Tanking This Week
September 30, 2021
From Motley Fool
A growing number of parents want to have their young children vaccinated as soon as possible
September 30, 2021
From MarketWatch
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
September 30, 2021
From Motley Fool
AstraZeneca vaccine shows 74% efficacy in large U.S.-backed trial, and BioNTech co-founder says COVID will become manageable
September 30, 2021
From MarketWatch
From Motley Fool
Here's a Chart That Every Pfizer Investor Needs to See
September 30, 2021
From Motley Fool
NIH-Backed US Study Of Mixed COVID-19 Vaccines Regime To Conclude Soon: CNBC
September 29, 2021
From Benzinga
Is Moderna's Booster COVID-19 Shot Moving Closer to Authorization?
September 29, 2021
From Benzinga
CDC study finds side effects from COVID-19 vaccine booster are the same as after second shot, as experts urge unvaccinated to get their first shots
September 29, 2021
From MarketWatch
The Delta Variant Has Made Quest Diagnostics Indispensable
September 29, 2021
From Motley Fool
Pfizer’s COVID vaccine for kids might not get FDA approval until November
September 28, 2021
From MarketWatch
Is there an economic argument for COVID-19 boosters?
September 28, 2021
From MarketWatch
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.